The purpose of this study was to determine the impact of coronavirus disease 2019 (COVID-19) on the delayed presentation of necrotising fasciitis (NF). A retrospective study was conducted of adult patients (≥16 years old) diagnosed with NF at a hospital from 2017 to 2020. A quantitative comparative analysis for the COVID-19 group and control group between 2017 and 2019. Structured interviews were conducted to examine the impact of COVID-19 on patients. There were 6 patients in the COVID-19 group and 10 patients in the control group. The COVID-19 group had a longer mean onset of symptoms till hospital presentation of 4.1 days and a longer mean operative time. The COVID-19 group was more likely to be admitted to intensive care unit. Three patients in the COVID-19 group did not survive compared to survival in the counterparts. Participant responses indicated the COVID-19 pandemic did not prevent them from presenting to ED.
Objective: Researching on some clinical characteristics and treatment results of epistaxis. Method: 60 patients with epistaxis at ENT Department – Hue Central Hospital from 10/2012 to 10/2014 were taken by an descriptive study with clinical interventions. Results: Epistaxis was most common in males (78,3%), one side of nose cavity (76%), mild haemorrhage (85%). There were 40% patient without interventions. Nasal packing was the first indicated (60%). The rate of stop nosebleeding by nasal packing was 23,3%, by eclectrocautery was 37,7%. Combining eclectrocautery and suction was an effective method for treatment epistaxis. Conclusions: Nasal endoscopic and electrocautery were an effective method for treatment epistaxis. Key words: epistaxis, nasal endoscopic
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.